pneumonia OpGen, Fisher Healthcare Ink Distribution Deal for Unyvero MDx System The nonexclusive distribution partnership is expected to increase US commercial adoption of the highly multiplexed PCR system. Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike Premium Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies. Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections. Sequencing Study Highlights Vaccine-Dodging Streptococcus Pneumoniae Lineage Researchers turned to whole-genome sequences to characterize S. pneumoniae serotypes that became prominent after the introduction of a pneumococcal conjugate vaccine. OpGen Unyvero Pneumonia Panel Helps Curb Inappropriate Antibiotic Use in Prospective Trial Premium The company expects the trial results to bolster sales by increasing physician confidence in the panel. Mar 1, 2021 OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval May 19, 2020 BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases Premium Apr 21, 2020 Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients Dec 20, 2019 FDA Clears Curetis Lower Respiratory Tract Infections Panel Jun 10, 2019 Streptococcus Pneumoniae Changes in Response to Vaccine Introduction, Global Genomic Survey Finds Apr 11, 2019 Curetis 2018 Revenues Grow 17 Percent Feb 6, 2019 AstraZeneca Spinoff Entasis Inks Deal to Use BioFire Tests Feb 4, 2019 Curetis Partner Submits MDx System, Pneumonia Test for Chinese Regulatory Approval Jan 30, 2019 Curetis Receives Malaysia, Thailand Regulatory Approvals Dec 13, 2018 Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring Nov 13, 2018 BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark Oct 11, 2018 Curetis Extends Distribution Agreement With Beijing Clear Biotech in China May 17, 2018 Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test Apr 19, 2018 BioMérieux Q1 Revenues Up 3 Percent Apr 4, 2018 Curetis Unyvero System, Lower Respiratory Tract Infection Cartridge Get FDA Clearance Feb 6, 2018 Curetis Gets Singapore Approval for Pneumonia Test Jul 31, 2017 IDbyDNA, ARUP Laboratories Partner to Develop, Commercialize NGS Infectious Disease Tests May 12, 2017 Metagenomic Analysis Tool Taxonomer IDs Multiple Pathogens From Clinical Samples May 11, 2017 With New Instrument and Assay Claims, BioMérieux Takes on Antibiotic Stewardship Premium Oct 26, 2016 Curetis Wraps Up US Clinical Trial for Lower Respiratory Infection Panel; Readies FDA Submission Premium Load More Breaking News NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore FDA Approves Entrogen's RAS Mutation Detection Kit as CDx for Vectibix Cancer Predisposition Variants Increase Secondary Cancer Mortality Risk in Pediatric Survivors BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects KromaTid, Noble Life Sciences Ink Distribution, OEM Agreement The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.